TPWA
BIO icon

Twin Peaks Wealth Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History

Twin Peaks Wealth Advisors’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3
Closed -$836 – 465
2026
Q1 		$836 Buy
+3
New +$864 ﹤0.01% 1939
2025
Q3 		– Sell
-3
Closed -$824 – 402
2025
Q2 		$824 Buy
+3
New +$709 ﹤0.01% 1813

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Twin Peaks Wealth Advisors's BIO Position: Q2 2026 in Review

Twin Peaks Wealth Advisors sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2026, closing a stake of 3 shares — an estimated $836 sold.

Twin Peaks Wealth Advisors first reported a position in BIO in Q2 2025 and held it in 2 quarters. The position peaked at $836 in Q1 2026. 397 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Twin Peaks Wealth Advisors reported no remaining Bio-Rad Laboratories Class A position as of Q2 2026 after selling out during the quarter.
  • Twin Peaks Wealth Advisors sold 3 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $836.
  • Twin Peaks Wealth Advisors first reported a position in Bio-Rad Laboratories Class A in Q2 2025 and held it in 2 quarters.
  • Twin Peaks Wealth Advisors's Bio-Rad Laboratories Class A position peaked at $836 in Q1 2026.
  • 397 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Twin Peaks Wealth Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.